14.97USDMkt Cap: 1.03B USDP/E: —Last update: 2026-05-22
Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery sy…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Company
Market Cap1.03B USD
Enterprise Value1.24B USD
Revenue (TTM)1.03B USD
Gross Profit546.01M USD
Net Income (TTM)-204.71M USD
Revenue/Share15.16 USD
Last Price14.97 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.5K
CountryUS
SectorHealthcare
IndustryMedical Devices
ISINUS8753722037
Valuation
P/E (Trailing)—
P/E (Forward)299.34
PEG—
EV/EBITDA-28.81
EV/Revenue1.21
P/S1.05
P/B6.94
EPS (TTM)-1.37
EPS (Forward)0.05
52W Range
14.943% of range15.91
52W High15.91 USD
52W Low14.94 USD
Profitability
Gross Margin53.81%
Oper. Margin-7.05%
EBITDA Margin-4.21%
Profit Margin-20.17%
ROE-131.93%
ROA-23.23%
Growth
Revenue Growth5.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.72M USD
CapEx (TTM)98.54M USD
FCF Margin-1.97%
FCF Yield-1.98%
Net Debt164.48M USD
Net Debt/EBITDA-3.81
Balance Sheet
Debt/Equity2.86
Current Ratio3.58
Quick Ratio2.87
Book Value/Sh2.272 USD
Cash/Share8.321 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 10, 2017
Splits
Last Split1:10
Split DateOct 10, 2017
Analyst Consensus
Rating2.1 (Buy)
Target (Mean)30.52 USD
Target Range20.00 USD – 55.00 USD
# Analysts21
Ownership
Shares Out.68.53M
Float62.99M
Insiders0.86%
Institutions117.98%
Short Interest
Short Ratio6.1d
Short % Float19.11%
Short % Out.14.19%
Shares Short9.72M
Short (prev mo.)10.53M
Technical
SMA 5019.46 (-23.1%)
SMA 20018.02 (-16.9%)
Beta1.64
S&P 52W Chg28.31%
Avg Vol (30d)1.94M
Avg Vol (10d)3.63M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—